RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024